YPrime Site Report Cover
YPrime Survey Finds 62% of Clinical Site Staff Report eCOA Platforms are Misaligned with Site Needs
September 25, 2024 09:00 ET | Y-Prime, LLC
YPrime releases report on site technology experiences, offering sponsors insights to improve trial efficiency by aligning eCOA platforms with user needs.
YPrime CNS Survey - Key eCOA Attributes
New YPrime Report Highlights eCOA's Impact on CNS Trials
May 01, 2024 08:00 ET | Y-Prime, LLC
YPrime has released a new report, Insights into CNS Clinical Trials, which demonstrates to sponsors how eCOA can help streamline CNS research.
YPrime Brand Launch Image
YPrime Unveils a Transformative Brand Focused on Solving for Certainty in Clinical Trials
January 22, 2024 07:45 ET | Y-Prime, LLC
YPrime announces bold rebranding and re-commitment to provide cutting-edge technologies to streamline and accelerate clinical trials.
Micron logo_blue_RGB.jpg
Micron Announces New Semiconductor Assembly and Test Facility in India
June 22, 2023 07:00 ET | Micron Technology, Inc.
BOISE, Idaho, June 22, 2023 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (NASDAQ: MU), one of the world’s largest semiconductor companies, today announced plans to build a new assembly and test...
Full Logo - OKYO .jpg
OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease
April 25, 2023 02:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, April 25, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101...
EROLD_Logo.png
Erold SA : Chiffre d’affaires du 1er semestre 2022
July 27, 2022 11:45 ET | Erold SA
Chiffre d’affaires du 1er semestre 2022 Erold (FR0010211037 – ALPLA), groupe média numérique indépendant, annonce ce jour son chiffre d’affaires pour le 1er semestre 2022, clos le 30 juin 2022. En...
logo-dark.png
Aegis Sciences Corporation and Walgreens announce expansion of COVID-19 diagnostic testing
February 11, 2021 08:00 ET | Aegis Sciences Corporation
NASHVILLE, Tenn. and DEERFIELD, Ill., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and...
logo-dark.png
Aegis Sciences Corporation Launches Combined Test for SARS-CoV-2 and Influenza A/B Virus
November 16, 2020 11:20 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
logo-dark.png
Aegis Sciences Corporation Announces National Launch of COVID-19 Antibody Testing Utilizing Convenient Dry Blood Spot Technology
August 31, 2020 10:30 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...
logo-dark.png
Aegis Sciences Corporation Testing for Coronavirus Disease 2019 (COVID-19) Now Authorized to Report in all 50 states
June 09, 2020 12:11 ET | Aegis Sciences Corporation
NASHVILLE, Tenn., June 09, 2020 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services...